packageLusutrombopag

lusutrombopag

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Lusutrombopag is a medicine used to treat thrombocytopenia, a condition of low blood platelets. It is an approved drug and is authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q27265116 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:lusutrombopag
ATC codes:B02BX07
DrugBank:DB13125
PubChem CID:49843517
ChEBI:136051
Wikidata:Q27265116
formula:C29H32Cl2N2O5S
molar mass:591.544 g/mol (PubChem CID 49843517)
logP:7.7 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown